Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer : An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Morgan, Philip James, Woolacott, Nerys Frances orcid.org/0000-0003-1562-8311, Biswas, Mousumi orcid.org/0000-0001-6781-7400 et al. (3 more authors) (2017) Crizotinib for Untreated Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer : An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. pp. 1-11. ISSN 1179-2027

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017, Crown Copyright. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.
Dates:
  • Published (online): 24 March 2017
Institution: The University of York
Academic Units: The University of York > Faculty of Social Sciences (York) > Centre for Reviews and Dissemination (York)
Depositing User: Pure (York)
Date Deposited: 24 Jul 2018 23:28
Last Modified: 13 Nov 2019 11:57
Published Version: https://doi.org/10.1007/s40273-017-0497-1
Status: Published online
Refereed: No
Identification Number: https://doi.org/10.1007/s40273-017-0497-1

Download

Filename: Crizotinib_Publication_.pdf

Description: Crizotinib Publication

Share / Export

Statistics